AAAAAA

   
Results: 1-7 |
Results: 7
THE COST-EFFECTIVENESS OF PNEUMOCOCCAL VACCINATION STRATEGIES (VOL 12, PG 161, 1997)
Authors: GABLE CB BOTTEMAN M SAVAGE G
Citation: Cb. Gable et al., THE COST-EFFECTIVENESS OF PNEUMOCOCCAL VACCINATION STRATEGIES (VOL 12, PG 161, 1997), PharmacoEconomics, 12(6), 1997, pp. 706-706
THE COST-EFFECTIVENESS OF PNEUMOCOCCAL VACCINATION STRATEGIES
Authors: GABLE CB BOTTEMAN M SAVAGE G JOY K
Citation: Cb. Gable et al., THE COST-EFFECTIVENESS OF PNEUMOCOCCAL VACCINATION STRATEGIES, PharmacoEconomics, 12(2), 1997, pp. 161-174
LIFETIME COSTS OF HIV AIDS MEDICAL-CARE - REPLY/
Authors: GABLE CB
Citation: Cb. Gable, LIFETIME COSTS OF HIV AIDS MEDICAL-CARE - REPLY/, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 381-381
COSTS OF HIV+ AIDS AT CD4(+) COUNTS DISEASE STAGES BASED ON TREATMENTPROTOCOLS/
Authors: GABLE CB TIERCE JC SIMISON D WARD D MOTTE K
Citation: Cb. Gable et al., COSTS OF HIV+ AIDS AT CD4(+) COUNTS DISEASE STAGES BASED ON TREATMENTPROTOCOLS/, Journal of acquired immune deficiency syndromes and human retrovirology, 12(4), 1996, pp. 413-420
ANTIHISTAMINES AND RISK OF CARDIAC EVENTS
Authors: VERSPEELT J AMERY W JONES J STAFFA J GABLE CB
Citation: J. Verspeelt et al., ANTIHISTAMINES AND RISK OF CARDIAC EVENTS, Journal of allergy and clinical immunology, 97(1), 1996, pp. 638-638
METHODOLOGIES FOR PHARMACEUTICAL EFFECTIVENESS AND PHARMACOECONOMICS RESEARCH
Authors: GABLE CB
Citation: Cb. Gable, METHODOLOGIES FOR PHARMACEUTICAL EFFECTIVENESS AND PHARMACOECONOMICS RESEARCH, Pharmaceutical research, 12(9), 1995, pp. 1248-1249
RISK OF SELECTED SERIOUS CARDIAC EVENTS AMONG NEW USERS OF ANTIHISTAMINES
Authors: STAFFA JA JONES JK GABLE CB VERSPEELT JP AMERY WK
Citation: Ja. Staffa et al., RISK OF SELECTED SERIOUS CARDIAC EVENTS AMONG NEW USERS OF ANTIHISTAMINES, Clinical therapeutics, 17(6), 1995, pp. 1062-1077
Risultati: 1-7 |